News

Get more out of your business.

Reach it with Microsoft Dynamics 365 Business Central.

May 10, 2019 signalgroup

The Biosimilars Forum Comments on FDA’s New Interchangeability Guidance for Industry

March 19, 2019 Katie Quinn

Significant Healthcare Savings Possible if U.S. Cultivates a Robust Biosimilars Market

March 7, 2019 Katie Quinn

The Biosimilars Forum Disagrees with the Food and Drug Administration’s Decision on Naming of Biologic Medicines

March 6, 2019 Katie Quinn

The Biosimilars Forum Recognizes Commissioner Gottlieb’s Leadership Supporting a Strong Biosimilars Market in the U.S.

February 26, 2019 Katie Quinn

Removing 340B Pass-Through Would be Detrimental to US Healthcare Savings

February 26, 2019 Katie Quinn

The Biosimilars Forum Urges Senate Finance Committee to Seek Meaningful Biosimilars Reform

February 12, 2019 Katie Quinn

The Biosimilars Forum Objects to Consolidate Billing of Biosimilars

February 1, 2019 Katie Quinn

The Biosimilar Forum Recognizes Leah Christl’s Departure from FDA

January 31, 2019 Katie Quinn

The Biosimilars Forum Applauds HHS Proposal to Target Costly Rebates Structure Blocking Patients from Biosimilars and Savings

December 13, 2018 Katie Quinn

The Biosimilars Forum Commends FDA for Commitment to Increase Patient Access to Biosimilars